IEEE Spectrum on MSN8h
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
Study Finds on MSN2d
Researchers uncover serious flaw in promising Alzheimer’s blood testsNew research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
Feb. 26, 2025 — ALS, or amyotrophic lateral sclerosis ... 2025 — A new artificial intelligence model measures how fast a patient's brain is aging and could be a powerful new tool for ...
StudyFinds on MSN9d
Breakthrough blood test could transform ALS diagnosis, careFind out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
ALS, also known as Lou Gehrig’s disease, is a progressive disease that affects nerve cells in the brain and spinal cord.
Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
ALS, also known as Lou Gehrig's disease, is a progressive disease that affects nerve cells in the brain and spinal cord. Nerves that signal and control muscles degenerate, causing patients to lose ...
Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback